Senator Investment Group LP Bristol Myers Squibb CO Transaction History

Senator Investment Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $53.4 Million - $60.1 Million	-900,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $52 Million - $58.9 Million	900,000 New	900,000 $55.8 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $144 Million - $159 Million	-2,500,000 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $27.4 Million - $32 Million	-500,000 Reduced 16.67%	2,500,000 $8.9 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $23.2 Million - $33.7 Million	500,000 Added 20.0%	3,000,000 $11.5 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $123 Million - $160 Million	2,500,000 New	2,500,000 $7.69 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

Stay updated on Senator Investment Group LP with notifications on news.